AI Dermatology Apps: Classifying Melanoma Risk With Smartphones

Dermatology artificial intelligence applications leverage smartphone cameras and advanced machine learning algorithms to assess skin lesions for melanoma risk. This article explores the end-to-end process of how these tools work, from the initial image capture and preprocessing to lesion segmentation, feature extraction, and the final risk classification generated by deep neural networks.

Image Capture and Preprocessing

The process begins when a user takes a photograph of a skin lesion using a smartphone. Because smartphone photos vary wildly in quality, lighting, and angle, the AI application must first standardize the image through preprocessing.

During this phase, the software applies algorithms to correct color imbalances caused by artificial lighting or camera flashes. It also crops the image, enhances contrast, and removes visual artifacts that could confuse the AI, such as skin hair, air bubbles, or ruler markings.

Lesion Segmentation

Once the image is cleaned, the application must separate the actual skin lesion from the surrounding healthy skin. This step is called segmentation.

The AI scans the pixels to identify the exact borders of the mole or spot. By analyzing sudden changes in pixel color, intensity, and texture, the software draws a digital boundary around the lesion. Accurate segmentation ensures the AI only analyzes the abnormal tissue and ignores the normal skin background.

Feature Extraction and the ABCDE Criteria

Historically, dermatologists evaluate melanoma using the ABCDE criteria: Asymmetry, Border irregularity, Color variation, Diameter, and Evolution. Modern dermatology apps use Convolutional Neural Networks (CNNs) to perform a digitized, mathematical version of this assessment.

Instead of just looking at the surface, the CNN breaks the segmented lesion down into thousands of tiny pixel patterns. It extracts both visual and non-visual features, including:

• Geometrical features: Measuring the symmetry and the jaggedness of the borders.
• Colorimetric features: Analyzing the distribution and variance of brown, black, red, white, or blue pixels within the lesion.
• Textural features: Detecting subtle patterns in skin roughness or smoothness that are invisible to the naked eye.

Deep Learning Classification

The core of the risk assessment relies on how the CNN was trained. Developers feed the AI hundreds of thousands of clinical images of skin lesions that have already been biopsied and diagnosed by medical professionals as either benign (harmless) or malignant (cancerous, such as melanoma).

When a user uploads a new smartphone photo, the AI compares the extracted features of the user's lesion against the patterns it learned from the training database. The neural network passes this data through multiple interconnected layers, narrowing down the possibilities until it calculates a statistical probability of malignancy.

Risk Output and Triage

The final step is translating the statistical probability into a clear result for the user. Rather than providing a definitive medical diagnosis, these applications act as triage tools.

Based on a predetermined threshold, the app categorizes the lesion into risk tiers—typically Low Risk, Medium Risk, or High Risk. If the mathematical probability of melanoma crosses a specific threshold, the application flags the lesion as high risk and instructs the user to seek an immediate in-person evaluation and biopsy from a board-certified dermatologist.